179 related articles for article (PubMed ID: 8722358)
1. Activation of coagulation and deep vein thrombosis after bone marrow harvesting and insertion of a Hickman-catheter in ABMT patients with malignant lymphoma.
Sletnes KE; Holte H; Halvorsen S; Jakobsen E; Wisløff F; Kvaløy S
Bone Marrow Transplant; 1996 Apr; 17(4):577-81. PubMed ID: 8722358
[TBL] [Abstract][Full Text] [Related]
2. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis.
Jansen FH; van der Straaten HM; Roest M; Haas F; de Groot PG; Fijnheer R
Haematologica; 2005 Apr; 90(4):499-504. PubMed ID: 15820946
[TBL] [Abstract][Full Text] [Related]
4. Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation.
Conlan MG; Haire WD; Lieberman RP; Lund G; Kessinger A; Armitage JO
Bone Marrow Transplant; 1991 Mar; 7(3):235-40. PubMed ID: 1676322
[TBL] [Abstract][Full Text] [Related]
5. The John Charnley Award. Thrombogenesis during total hip arthroplasty.
Sharrock NE; Go G; Harpel PC; Ranawat CS; Sculco TP; Salvati EA
Clin Orthop Relat Res; 1995 Oct; (319):16-27. PubMed ID: 7554626
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis.
Lee A
Haematologica; 2005 Apr; 90(4):437. PubMed ID: 15820933
[TBL] [Abstract][Full Text] [Related]
7. Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies.
Catani L; Gugliotta L; Mattioli Belmonte M; Vianelli N; Gherlinzoni F; Miggiano MC; Belardinelli AR; Rosti G; Calori E; Bandini G
Bone Marrow Transplant; 1993 Sep; 12(3):253-9. PubMed ID: 8241985
[TBL] [Abstract][Full Text] [Related]
8. Hemorheological alterations and hypercoagulable state in deep vein thrombosis.
Mira Y; Vayá A; Martínez M; Villa P; Santaolaria ML; Ferrando F; Aznar J
Clin Hemorheol Microcirc; 1998 Dec; 19(4):265-70. PubMed ID: 9972663
[TBL] [Abstract][Full Text] [Related]
9. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
10. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma.
Gordon B; Haire W; Kessinger A; Duggan M; Armitage J
Bone Marrow Transplant; 1991 Dec; 8(6):497-502. PubMed ID: 1790430
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
[TBL] [Abstract][Full Text] [Related]
12. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
van Besien K; Margolin K; Champlin R; Forman S
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
[TBL] [Abstract][Full Text] [Related]
13. Prothrombotic hemostatic abnormalities in patients with refractory malignant lymphoma presenting for autologous stem cell transplantation.
Conlan MG; Haire WD; Kessinger A; Armitage JO
Bone Marrow Transplant; 1991 Jun; 7(6):475-9. PubMed ID: 1873594
[TBL] [Abstract][Full Text] [Related]
14. Invasive fungal infections in lymphoma patients receiving immunotherapy following autologous bone marrow transplantation (ABMT).
Toren A; Or R; Ackerstein A; Nagler A
Bone Marrow Transplant; 1997 Jul; 20(1):67-9. PubMed ID: 9232260
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of heparin responses in arterial and venous thromboembolism using molecular markers for thrombosis.
Sobel M; Sternbergh WC; Marques D; Grimsdale AS
Circulation; 1993 Nov; 88(5 Pt 2):II426-31. PubMed ID: 8222189
[TBL] [Abstract][Full Text] [Related]
16. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
Dann EJ; Daugherty CK; Larson RA
Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
[TBL] [Abstract][Full Text] [Related]
18. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
19. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D
Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
